Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Featured products

Featured products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC7797 ML365 Featured
ML365 is a novel selective small molecule inhibitor of TASK1(KCNK3) with IC50 of 4 nM(thallium influx fluorescent assay) and 16 nM(automated electrophysiology assay).
More description
DC10091 ML364 Featured
ML364 is an USP2 inhibitor.xtracted from patent WO 2016134026 A1, compound example 10G.
More description
DC9994 ML-346 Featured
ML346 is a novel activator of Hsp70 with EC50 of 4600 nM in HeLa cell toxicity assay.
More description
DC10743 ml335 Featured
ML335 is a selective activator of both TREK-1 and TREK-2.
More description
DC10121 ML-329 Featured
ML329 is a small molecule inhibitor of the MITF molecular pathway.
More description
DC10711 ML-327 Featured
ML327 is a blocker of MYC which can also de-repress E-cadherin transcription and reverse Epithelial-to-Mesenchymal Transition (EMT).
More description
DC7740 ML-324 Featured
ML-324 is a JMJD2 histone demethylase inhibitor (JMJD2 IC50 = 920 nM)
More description
DC7468 ML-323 Featured
ML323 is a reversible, potent USP1-UAF1 inhibitor with IC50 of 76 nM in a Ub-Rho assay and 174 nM and 820 nM in orthogonal gel-based assays using K63-linked diubiquitin (di-Ub) and monoubiquitinated PCNA (Ub-PCNA) as substrates, respectively.
More description
DC7798 ML-277 Featured
ML-277 is a potent activator of KCNQ1 ( K(v)7.1) channels (EC50 = 260 nM).
More description
DC9682 ML-264 Featured
ML264 is a novel small molecule inhibitor of Krüppel-like factor 5 (KLF5).
More description
DC10790 ML-239 Featured
ML-239 is an inhibitor of cancer stem cells, displaying greater than 23-fold selective inhibition of a breast cancer stem cell-like cell line (EC50 = 1.18 µM) over an isogenic control cell line (EC50 = 27.6 µM).
More description
DC7781 ML-224 Featured
ML-224 (ANTAG3) is a selective TSH receptor antagonist inhibits stimulation of thyroid function in female mice.
More description
DC10793 ML221 Featured
ML221 is an antagonist of the apelin (APJ) receptor.
More description
DC10466 ML-18 Featured
ML18 is Bombesin receptor subtype 3 (BRS-3) antagonist (IC50 = 4.8 μM). ML-18 inhibits lung cancer growth.
More description
DC7901 ML-141 Featured
ML141 is a potent, selective and reversible non-competitive inhibitor of Rho family GTPase cdc42 with IC50 of 200 nM.
More description
DC7467 ML-098 Featured
ML-098 is an activator of the GTP-binding protein Rab7 (EC50 = 77.6 nM) that demonstrates selectivity against the related GTPases cdc42, Ras, Rab-2A, and Rac1 (EC50s = 588.8, 346.7, 158.5, and 794.3 nM, respectively).
More description
DC9874 ML-348(ML348) Featured
ML 348(ML348) is a selective and reversible lysophospholipase 1 (LYPLA1) inhibitor (IC50 = 210 nM).
More description
DC10544 MKC3946 Featured
MKC3946 is a potent and soluble IRE1α inhibitor, used for cancer research.
More description
DC9901 Verubecestat (MK-8931) Featured
MK-8931 is a BACE1 inhibitor. MK-8931 binds significantly to β-secretase.
More description
DC12020 MK-8722 Featured
MK-8722 is a systemic, Direct Pan-Activator of AMP-Activated Protein Kinase.
More description
DC5034 MK8245 Featured
MK-8245 is an liver-targeting inhibitor of stearoyl-CoA desaturase (SCD) with IC50 of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1, with anti-diabetic and anti-dyslipidemic efficacy.
More description
DC7745 Filorexant(mk-6096) Featured
MK-6096 is an orally bioavailable potent and selective reversible antagonist of OX(1)R and OX(2)R currently in clinical development for insomnia.
More description
DC4179 Niraparib(MK4827) free base Featured
MK-4827 is an inhibitor of poly (ADP-ribose) polymerase (PARP) with potential antineoplastic activity.
More description
DC7465 MK-2206 2HCl Featured
MK-2206 2HCl is a highly selective inhibitor of Akt1/2/3 with IC50 of 8 nM/12 nM/65 nM, respectively; no inhibitory activities against 250 other protein kinases observed. Phase 2.
More description
DC1070 MK-1775(AZD-1775,Adavosertib) Featured
MK-1775 is a potent and selective Wee1 inhibitor with IC50 of 5.2 nM.
More description
DC9966 MK-1064 Featured
MK-1064 is a selective orexin 2 receptor antagonist (2-SORA) for the research of insomnia.
More description
DC8041 MK-0941 Featured
MK-0941 is a novel Glucokinase activator (GKA)
More description
DC10045 MK-0557 Featured
MK-0557 is a highly selective, orally administered neuropeptide NPY5R antagonist, could limit weight regain after very-low-calorie diet (VLCD)-induced weight loss.
More description
DC9836 Mivebresib(ABBV-075) Featured
Mivebresib is a novel BET family inhibitor, disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo.
More description
DC8935 Mitomycin C Featured
Mitomycin C is a DNA crosslinking agent that inhibits DNA synthesis and induces apoptosis in a variety of cells.
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X